✦ LIBER ✦

Reasons for referral to bone densitometry in men and women aged 20–49

✍ Scribed by Alice M. J. Torpy,Sharon L. Brennan,Mark A. Kotowicz…

Book ID: 126362885
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 128 KB
Volume: 7
Category: Article
ISSN: 1862-3522
DOI: 10.1007/s11657-012-0094-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heavy Phenacetin Use and Bladder Cancer

Heavy Phenacetin Use and Bladder Cancer in Women Aged 20 to 49 Years

✍ Piper, Joyce M.; Tonascia, James; Matanoski, Genevieve M. 📂 Article 📅 1985 🏛 Massachusetts Medical Society 🌐 English ⚖ 677 KB

Structural adaptations to bone loss in a

Structural adaptations to bone loss in aging men and women

✍ Cosimo Roberto Russo; Fulvio Lauretani; Ego Seeman; Benedetta Bartali; Stefania 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 486 KB

Cost-effectiveness of bone densitometry

Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight

✍ J. T. Schousboe, M. Gourlay, H. A. Fink, B. C. Taylor, E. S. Orwoll, E. Barrett- 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 345 KB

Age-Related Trends in Phalangeal Bone Mi

✍ Lekamwasam, Sarath; Wijerathne, Lalith; Rodrigo, Mahinda; Hewage, Udul 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Relation of age, gender, and bone mass t

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

✍ Ulrike I Mödder; Kelley A Hoey; Shreyasee Amin; Louise K McCready; Sara J Achenb 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 278 KB 👁 2 views

Relation of age, gender, and bone mass t

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

✍ Ulrike I Mödder; Kelley A Hoey; Shreyasee Amin; Louise K McCready; Sara J Achenb 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 278 KB 👁 2 views

Sclerostin is a potent inhibitor of Wnt signaling and bone formation. However, there is currently no information on the relation of circulating sclerostin levels to age, gender, or bone mass in humans. Thus we measured serum sclerostin levels in a population-based sample of 362 women [123 premenopau